Sex
Visit (Number) vs PM Diastolic Blood Presure 1st Measurement
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
| Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
| Diagnostic Visit (DX) | 1,232 | 77.6 | ± 12.8 | 78.0 | -2.0 | 120.0 | 284 | 1,516 |
| CPAP Titration Visit (CPAP) | 1,056 | 76.9 | ± 13.4 | 78.0 | -1.0 | 130.0 | 460 | 1,516 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 76.6 | ± 13.2 | 78.0 | -1.0 | 130.0 | 637 | 1,516 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 9.3 | ± 28.4 | -2.0 | -2.0 | 118.0 | 683 | 1,516 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 75.8 | ± 14.5 | 78.0 | -3.0 | 110.0 | 665 | 1,516 |
Gender vs PM Diastolic Blood Presure 1st Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Diastolic Blood Presure 1st Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs PM Diastolic Blood Presure 1st Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 77.6 | ± 12.8 | 78.0 | -2.0 | 120.0 | 284 | 1,516 |
| Male | 788 | 78.6 | ± 12.3 | 80.0 | -1.0 | 120.0 | 170 | 958 |
| Female | 444 | 76.0 | ± 13.7 | 78.0 | -2.0 | 118.0 | 114 | 558 |
Gender vs PM Diastolic Blood Presure 1st Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 76.9 | ± 13.4 | 78.0 | -1.0 | 130.0 | 460 | 1,516 |
| Male | 693 | 77.9 | ± 12.3 | 78.0 | -1.0 | 130.0 | 265 | 958 |
| Female | 363 | 74.9 | ± 15.2 | 78.0 | -1.0 | 110.0 | 195 | 558 |
Gender vs PM Diastolic Blood Presure 1st Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 76.6 | ± 13.2 | 78.0 | -1.0 | 130.0 | 637 | 1,516 |
| Male | 572 | 77.0 | ± 13.6 | 78.0 | -1.0 | 130.0 | 386 | 958 |
| Female | 307 | 75.8 | ± 12.4 | 78.0 | -1.0 | 110.0 | 251 | 558 |
Gender vs PM Diastolic Blood Presure 1st Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 9.3 | ± 28.4 | -2.0 | -2.0 | 118.0 | 683 | 1,516 |
| Male | 541 | 9.3 | ± 28.7 | -2.0 | -2.0 | 118.0 | 417 | 958 |
| Female | 292 | 9.2 | ± 27.7 | -2.0 | -2.0 | 98.0 | 266 | 558 |
Gender vs PM Diastolic Blood Presure 1st Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 75.8 | ± 14.5 | 78.0 | -3.0 | 110.0 | 665 | 1,516 |
| Male | 552 | 76.8 | ± 13.5 | 78.0 | -2.0 | 110.0 | 406 | 958 |
| Female | 299 | 74.0 | ± 16.2 | 76.0 | -3.0 | 108.0 | 259 | 558 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 77.6 | ± 12.8 | 78.0 | -2.0 | 120.0 | 284 | 1,516 |
| Native American | 20 | 79.2 | ± 15.0 | 75.0 | 64.0 | 120.0 | 8 | 28 |
| Asian | 74 | 76.9 | ± 11.2 | 80.0 | 58.0 | 108.0 | 15 | 89 |
| Black | 120 | 78.9 | ± 15.2 | 79.0 | -1.0 | 118.0 | 52 | 172 |
| Hispanic | 84 | 78.8 | ± 9.4 | 79.0 | 60.0 | 106.0 | 32 | 116 |
| White | 926 | 77.4 | ± 12.6 | 78.0 | -2.0 | 118.0 | 176 | 1,102 |
| Other | 8 | 73.9 | ± 32.5 | 81.0 | -1.0 | 102.0 | 1 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 76.9 | ± 13.4 | 78.0 | -1.0 | 130.0 | 460 | 1,516 |
| Native American | 16 | 84.3 | ± 16.4 | 82.0 | 65.0 | 120.0 | 12 | 28 |
| Asian | 58 | 76.2 | ± 9.0 | 76.0 | 56.0 | 108.0 | 31 | 89 |
| Black | 96 | 79.7 | ± 16.7 | 80.0 | -1.0 | 130.0 | 76 | 172 |
| Hispanic | 73 | 79.0 | ± 8.7 | 80.0 | 58.0 | 100.0 | 43 | 116 |
| White | 808 | 76.2 | ± 13.5 | 78.0 | -1.0 | 118.0 | 294 | 1,102 |
| Other | 5 | 85.6 | ± 14.0 | 90.0 | 64.0 | 102.0 | 4 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 76.6 | ± 13.2 | 78.0 | -1.0 | 130.0 | 637 | 1,516 |
| Native American | 13 | 79.6 | ± 28.1 | 88.0 | -1.0 | 114.0 | 15 | 28 |
| Asian | 49 | 74.6 | ± 9.6 | 75.0 | 52.0 | 96.0 | 40 | 89 |
| Black | 77 | 80.5 | ± 9.5 | 80.0 | 60.0 | 110.0 | 95 | 172 |
| Hispanic | 65 | 75.9 | ± 12.6 | 78.0 | -1.0 | 96.0 | 51 | 116 |
| White | 672 | 76.2 | ± 13.4 | 78.0 | -1.0 | 130.0 | 430 | 1,102 |
| Other | 3 | 88.7 | ± 8.1 | 90.0 | 80.0 | 96.0 | 6 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 9.3 | ± 28.4 | -2.0 | -2.0 | 118.0 | 683 | 1,516 |
| Native American | 10 | 4.2 | ± 19.6 | -2.0 | -2.0 | 60.0 | 18 | 28 |
| Asian | 47 | 8.0 | ± 26.6 | -2.0 | -2.0 | 90.0 | 42 | 89 |
| Black | 73 | 7.8 | ± 28.6 | -2.0 | -2.0 | 118.0 | 99 | 172 |
| Hispanic | 57 | 4.3 | ± 20.4 | -2.0 | -2.0 | 84.0 | 59 | 116 |
| White | 643 | 10.1 | ± 29.2 | -2.0 | -2.0 | 102.0 | 459 | 1,102 |
| Other | 3 | -2.0 | ± 0.0 | -2.0 | -2.0 | -2.0 | 6 | 9 |
Race/Ethnicity vs PM Diastolic Blood Presure 1st Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 75.8 | ± 14.5 | 78.0 | -3.0 | 110.0 | 665 | 1,516 |
| Native American | 13 | 78.8 | ± 27.0 | 80.0 | -1.0 | 110.0 | 15 | 28 |
| Asian | 50 | 75.5 | ± 8.9 | 75.0 | 60.0 | 100.0 | 39 | 89 |
| Black | 75 | 78.4 | ± 17.2 | 80.0 | -1.0 | 110.0 | 97 | 172 |
| Hispanic | 61 | 75.3 | ± 16.3 | 78.0 | -1.0 | 102.0 | 55 | 116 |
| White | 649 | 75.4 | ± 14.0 | 78.0 | -3.0 | 108.0 | 453 | 1,102 |
| Other | 3 | 92.0 | ± 8.0 | 92.0 | 84.0 | 100.0 | 6 | 9 |